Tri Locum Partners LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$435.1B
Holdings
18
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | JNJJOHNSON & JOHNSON | 302,831 | $56.2B | 12.91% | |
| 2 | UTHUNITED THERAPEUTICS CORP DEL | 122,187 | $51.2B | 11.77% | |
| 3 | MRKMERCK & CO INC | 446,874 | $37.5B | 8.62% | |
| 4 | AXSMAXSOME THERAPEUTICS INC | 292,137 | $35.5B | 8.16% | |
| 5 | ASNDASCENDIS PHARMA A/S | 174,829 | $34.8B | 7.99% | |
| 6 | VERAVERA THERAPEUTICS INC | 1,190,207 | $34.6B | 7.95% | |
| 7 | ARGXARGENX SE | 43,411 | $32.0B | 7.36% | |
| 8 | MDGLMADRIGAL PHARMACEUTICALS INC | 67,706 | $31.1B | 7.14% | |
| 9 | SLNOSOLENO THERAPEUTICS INC | 450,585 | $30.5B | 7.00% | |
| 10 | ABBVABBVIE INC | 89,621 | $20.8B | 4.77% | |
| 11 | KRROKORRO BIO INC | 337,764 | $16.2B | 3.72% | |
| 12 | XENEXENON PHARMACEUTICALS INC | 366,102 | $14.7B | 3.38% | |
| 13 | AVDLAVADEL PHARMACEUTICALS PLC | 724,859 | $11.1B | 2.54% | |
| 14 | STVNSTEVANATO GROUP S P A | 332,912 | $8.6B | 1.97% | |
| 15 | DNTHDIANTHUS THERAPEUTICS INC | 182,867 | $7.2B | 1.65% | |
| 16 | TARSTARSUS PHARMACEUTICALS INC | 119,260 | $7.1B | 1.63% | |
| 17 | PRAXPRAXIS PRECISION MEDICINES I | 75,986 | $4.0B | 0.93% | |
| 18 | BHVNBIOHAVEN LTD | 149,179 | $2.2B | 0.51% |